BTIG Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
BTIG analyst Julian Harrison reiterated a Buy rating and $10.00 price target on Connect Biopharma Holdings Ltd (NASDAQ: CNTB)The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
